AstraZeneca's $400 Billion Merger Talks with Bristol Myers Unraveled

A potential $400 billion merger between pharmaceutical giants AstraZeneca and Bristol Myers Squibb, which would have marked a return to mega-deals in the pharma sector, ultimately fell apart.

11 Aug, 05:59 — 11 Aug, 05:59

Post Share

Sources

Showing 1 of 1 sources

FTVery High4d ago

How AstraZeneca’s $400bn tie-up with US rival Bristol Myers unravelled

A merger between the giant drugmakers would have marked a return to pharma megadeals

Read full article →

PERSPECTA

PERSPECTA

AstraZeneca's $400 Billion Merger Talks with Bristol Myers Unraveled

Sources

How AstraZeneca’s $400bn tie-up with US rival Bristol Myers unravelled

Related Stories

Shah Rukh Khan, Ajay Devgn, Tiger Shroff Issued Notices Over Vimal Elaichi Ad

Belgrade Businessman Arrested for Multi-Million Dollar Fraud

Former Taco Bell CEO Criticizes McDonald's New Red Bull Drink

Spotify to Introduce Labels for AI-Generated Music

PERSPECTA